3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
37
Head and Neck Neoplasms
28
Prostatic Neoplasms
16
Oropharyngeal Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Uterine Cervical Neoplasms
8
Gliosarcoma
8
Glioblastoma
8
Carcinoma, Squamous Cell
7
Brain Neoplasms
7
Tongue Neoplasms
6
Rectal Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Laryngeal Neoplasms
5
Astrocytoma
5
Papillomavirus Infections
4
Neoplasm Metastasis
4
Mouth Neoplasms
4
Sarcoma
3
Neoplasms
3
Hypopharyngeal Neoplasms
3
Glioma
3
Carcinoma
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Stomatitis
2
Rhabdomyosarcoma
2
Radiation Injuries
2
Interventions
selpercatinib
2
pralsetinib
2
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Carboplatin
2
patritumab
1
osimertinib
1
napabucasin
1
efineptakin alfa
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Proton Therapy
1
Metformin
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thoracic Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
No trials found.